Version 1
: Received: 21 March 2020 / Approved: 23 March 2020 / Online: 23 March 2020 (07:19:35 CET)
How to cite:
Malik, Y. S.; Sircar, S.; Bhat, S.; Vinodhkumar, O. R.; Tiwari, R.; Sah, R.; Rabaan, A. A.; Rodriguez-Morales, A. J.; Dhama, K. Emerging Coronavirus Disease (COVID-19), a Pandemic Public Health Emergency with Animal Linkages: Current Status Update. Preprints2020, 2020030343. https://doi.org/10.20944/preprints202003.0343.v1
Malik, Y. S.; Sircar, S.; Bhat, S.; Vinodhkumar, O. R.; Tiwari, R.; Sah, R.; Rabaan, A. A.; Rodriguez-Morales, A. J.; Dhama, K. Emerging Coronavirus Disease (COVID-19), a Pandemic Public Health Emergency with Animal Linkages: Current Status Update. Preprints 2020, 2020030343. https://doi.org/10.20944/preprints202003.0343.v1
Malik, Y. S.; Sircar, S.; Bhat, S.; Vinodhkumar, O. R.; Tiwari, R.; Sah, R.; Rabaan, A. A.; Rodriguez-Morales, A. J.; Dhama, K. Emerging Coronavirus Disease (COVID-19), a Pandemic Public Health Emergency with Animal Linkages: Current Status Update. Preprints2020, 2020030343. https://doi.org/10.20944/preprints202003.0343.v1
APA Style
Malik, Y. S., Sircar, S., Bhat, S., Vinodhkumar, O. R., Tiwari, R., Sah, R., Rabaan, A. A., Rodriguez-Morales, A. J., & Dhama, K. (2020). Emerging Coronavirus Disease (COVID-19), a Pandemic Public Health Emergency with Animal Linkages: Current Status Update. Preprints. https://doi.org/10.20944/preprints202003.0343.v1
Chicago/Turabian Style
Malik, Y. S., Alfonso J. Rodriguez-Morales and Kuldeep Dhama. 2020 "Emerging Coronavirus Disease (COVID-19), a Pandemic Public Health Emergency with Animal Linkages: Current Status Update" Preprints. https://doi.org/10.20944/preprints202003.0343.v1
Abstract
After the appearance of first cases of ‘pneumonia of unknown origin’ in the Wuhan city, China, during late 2019, the disease progressed fast. Its cause was identified as a novel coronavirus, named provisionally 2019-nCoV. Subsequently, an official name was given as SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) by the International Committee on Taxonomy of Viruses (ICTV) study group. The World Health Organization (WHO) named the Coronavirus disease-2019 as COVID-19. The epidemics of COVID-2019 have been recorded over 113 countries/territories/areas apart from China and filched more than 4292 humans, affecting severely around 1,18,326 cases in a short span. The status of COVID-2019 emergency revised by the WHO within 42 days from Public Health International Emergency (January 30, 2020) to a pandemic (March 11, 2020). Nonetheless, the case fatality rate (CFR) of the current epidemic is on the rise (between 2-4%), relatively is lower than the previous SARS-CoV (2002/2003) and MERS-CoV (2012) outbreaks. Even though investigations are on its way, the researchers across the globe have assumptions of animal-origin of current SARS-CoV-2. A recent case report provides evidence of mild COVID-2019 infection in a pet dog that acquired COVID-2019 infection from his owner in Hong Kong. The news on travellers associated spread across the globe have also put many countries on alert with the cancellation of tourist visa to all affected countries and postponement of events where international visits were required. A few diagnostic approaches, including quantitative and differential real-time polymerase chain reaction assays, have been recommended for the screening of the individuals at risk. In the absence of any selective vaccine against SARS-CoV-2, re-purposed drugs are advocated in many studies. This article discourse the current worldwide situation of COVID-2019 with information on virus, epidemiology, host, the role of animals, effective diagnosis, therapeutics, preventive and control approaches making people aware on the disease outcomes.
Keywords
coronavirus; 2019-nCoV; SARS-CoV-2; animal coronaviruses; COVID-19; bat coronavirus; zoonoses; epidemiology; transmission; diagnosis; antivirals; prevention and control
Subject
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
